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ABSTRACT. Here we present a nanostructured surface able to produce multivalent interactions 
between surface-bound ephrinB1 ligands and membrane EphB2 receptors. We created ephrinB1 
nanopatterns of regular size (<30 nm in diameter) by using self-assembled diblock copolymers. 
Next, we used a statistically enhanced version of the Number and Brightness technique, which 
can discriminate - with molecular sensitivity - the oligomeric states of diffusive species to 
quantitatively track the EphB2 receptor oligomerization process in real time. The results indicate 
that a stimulation using randomly distributed surface-bound ligands was not sufficient to fully 
induce receptor aggregation. Conversely, when nanopatterned onto our substrates, the ligands 
effectively induced a strong receptor oligomerization. This presentation of ligands improved the 
clustering efficiency of conventional ligand delivery systems, as it required a 9-fold lower ligand 
surface coverage and included faster receptor clustering kinetics compared to traditional 
crosslinked ligands. In conclusion, nanostructured diblock copolymers constitute a novel strategy 
to induce multivalent ligand-receptor interactions leading to a stronger, faster, and more efficient 
receptor activation, thus providing a useful strategy to precisely tune and potentiate receptor 
responses. The efficiency of these materials at inducing cell responses can benefit applications 
such as the design of new bioactive materials and drug-delivery systems.  
 
KEYWORDS. Nanopatterning, receptor clustering, multivalent interactions, diblock copolymers, 
Eph receptor, ephrin. 
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Ligand-receptor interactions at the cell membrane mediate the communication signaling between 
cells. Ligand stimulation triggers receptor activation, leading to receptor oligomerization or 
clustering events that are essential to transduce the intracellular signaling response.1 Multivalent 
interactions between ligand and receptors, in which the simultaneous binding of multiple ligands 
on multiple entities occurs, is an emerging strategy to fine-tune receptor clustering and 
downstream signaling.1-3 Multivalency strongly impacts intercellular communication mediated 
by cell receptors, a fundamental principle in many biological processes such as viral entry, 
immune response, and cellular phase separation.3-6 Presenting ligands in a multivalent manner 
allows for an efficient manipulation of receptor aggregation on live cell membranes and the 
ensuing signaling response in a number of instances.3,7,8 Novel nanomaterials such as self-
assembled nanoparticles and protein superstructures provide new opportunities in the 
development of multivalent ligand platforms.9,10 In nature, adenoviruses take advantage of 
multivalency by presenting clusters of cell-adhesive peptides on their surface. These bind to 
multiple integrin receptors simultaneously, leading the virus to enter the cells.4 Mimicking this 
strategy, nanoclusters of cell-adhesive peptides on gold-polymeric nanoparticles have been 
designed to improve gene delivery.4 Dendrimer nanoparticles, functionalized with multiple 
oligonucleotides, show improved binding avidity to complementary oligonucleotides, when there 
are more than 9 ligands per dendrimer, the established threshold value to initiate a multivalent 
interaction.11 Iron-oxide nanoparticles required only 4 tripeptide Arg-Gly-Asp ligands per 
particle to reduce endothelial cell adhesion by a factor of 25, and to extend nanoparticle blood 
half-life in vivo due to multivalency.12  
Ephrin (Eph) receptors are a family of receptor tyrosine kinases that bind to ephrin ligands 
upon intercellular contact. During development, Eph receptors act as positional cues in tissue 
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patterning by regulating cell adhesion and repulsion.2,13 Ephrin binding triggers high-order 
clustering of the Eph receptor, receptor activation by trans-phosphorylation, and the ensuing 
signal transduction. The mere presence of monomeric soluble ephrin ligands is not sufficient to 
induce Eph receptor activation or signaling. It requires ligands that are membrane bound or 
clustered, and the entire process is highly sensitive to their oligomeric nature.14-16 The standard 
strategy for aggregating ephrin ligands for multivalent stimulation is by incubating disulphide-
linked dimers of fragment crystallizable (Fc)-ephrin fusion proteins with antibodies against 
Fc.16,17 Upon binding, Eph receptors and ephrins nucleate, forming an heterotetramer, which 
induces the cross-phosphorylation of the Eph receptors.16 After nucleation, the Eph receptor 
aggregation proceeds, following standard polymerization-condensation dynamics. First, the 
accretion of monomers (polymerization) assembles a diverse range of oligomers facilitating the 
lateral propagation of the receptor signal. Next, phosphorylated oligomers coalesce, leading to 
large-scale clusters (condensation).18 The size and lifetime of the resulting Eph receptor clusters 
determine their adhesive or repulsive functionality for a cell.13 Receptor clustering is sensitive to 
the lateral mobility of the receptor and to its subsequent signaling towards the cytoskeleton 
modulating the cell invasion potential of breast cancer cells.2,19-21 Because Eph-ephrin 
interactions are highly sensitive to multivalent binding processes, several strategies have been 
developed to improve the standard antibody crosslinked ephrin presentation, and produce a more 
efficient Eph receptor clustering and downstream signaling.7,8 Soluble DNA origami-based 
nanostructures, termed nanocalipers, have been used as templates to present multivalent ephrin 
ligands with controlled interligand spacing. The distance between ephrin dimers turned out to be 
key at stimulating receptor phosphorylation.8 In contrast to traditional antibody-mediated ligand 
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clustering methodologies, soluble multivalent ephrin conjugated on hyaluronic acid chains 
efficiently promoted stem cell differentiation into neurons and increased neurogenesis in vivo.7  
While Eph-ephrin multivalent effects using soluble ligands have been reported previously, the 
present study is a first to demonstrate that such effects can also be obtained using clustered 
ligands on surfaces. We employed nanotechnology to produce nanoclusters of surface-bound 
ephrin ligands, which are highly efficient at inducing Eph receptor clustering through multivalent 
interactions. The presence of multivalent interactions could be confirmed by examining the 
aggregation dynamics of the Eph receptor in live cells. Understanding the assembly dynamics of 
receptor complexes is particularly challenging, due to the limited availability of methods that 
would be capable of reaching single-molecule sensitivities in the diffusive environment of living 
cell membranes, and thus capable of providing quantitative information on the stoichiometry of 
the different protein complexes. Methods, such as single molecule fluorescence and single 
particle tracking, have a limited capacity to discriminate between oligomer populations.22 While 
near-field scanning optical microscopy (NSOM) is capable of spatial resolutions below 100 nm, 
it cannot be performed on live cells.23 In this work, we take advantage of a recently developed 
technique, termed enhanced Number and Brightness (eN&B), to measure the kinetics of 
oligomerization of the Eph receptor in live cells.18 The sensitivity of this method reaches 
nanometer levels and can potentially discriminate among  different receptor aggregation 
responses. We employed eN&B to analyze the diversity and dynamics of Eph receptor clustering 
upon ephrin stimulation, assessing the efficiency of multivalent effects of surface-bound ephrin 
ligands assembled in nanoclusters, in comparison to alternative surface-bound non-clustered 
configurations.  
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Nanopatterning fabrication and characterization. Nanopatterned templates for the 
multivalent ligand aggregates were prepared, using diblock copolymers of polystyrene-block-
poly(methyl methacrylate) (PS-b-PMMA).24 Block copolymers self-assemble at nanometer 
scales without the use of expensive instruments, such as electron beam lithography, or 
nanoimprint lithography techniques.25 Additional relevant features are the controllable 
nanometric size and density of the ligand clusters, parameters that depend on the molecular 
weight of the copolymer and the content of each block.26 A cylinder-forming copolymer 
(polystyrene mass fraction of 0.78) was selected and thin films of the polymer were prepared by 
spin coating on top of glass coverslips. Our aim was to create hexagonal arrays of poly(methyl 
methacrylate) (PMMA) circular domains of a uniform nanometric size, evenly distributed across 
the substrate surface. Under thin film confinement, the polymer self-assembly is strongly 
influenced by the surface energetics. The chemical modification of the substrate leads to an 
effective energetically neutral surface for both blocks (the polystyrene (PS) and the PMMA), and 
results in block copolymer domains that are oriented perpendicular to the substrate.27,28 A 
random copolymer poly(styrene-co-methyl methacrylate) brush with an hydroxyl group was 
employed to chemically modify the surface of the glass substrate before depositing the PS-b-
PMMMA copolymer.29 This process created nanostructured surfaces with PMMA circular 
domains that were 29 nm in diameter and spaced 64 nm apart (Figure 1A). Fast Fourier 
transforms (FFT) of topographic atomic force microscopy (AFM) images exhibited a ring-like 
pattern that is characteristic of polycrystalline structures with randomly oriented grains.  
The nanostructured surfaces were used as templates to create patterns of ligand nanoclusters 
that were subsequently used to study potential multivalent ligand-receptor interactions. The 
PMMA block was selectively hydrolyzed to ensure the preferential covalent binding of the 
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ligands to the circular domains. The chemical structure of PMMA is characterized by the 
presence of pending methyl ester groups along the main chain of the polymer, which can be used 
as reactive points for surface modification.30 The hydrolysis of methyl ester groups under basic 
conditions generates carboxylic groups that can react with the amine residues of proteins.31 The 
block copolymer thin films were immersed in a sodium hydroxide aqueous solution to hydrolyze 
the PMMA domains and thereby force the surfaces to maintain their nanostructured morphology 
(Figure 1B). Then, the carboxylic groups were activated with 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS), causing them to react 
with amine-bearing molecules to produce the ligand nanopatterned surfaces. Hydrolysis 
optimization was determined by immobilizing Alexa Fluor 647 hydrazide fluorescent dyes and 
measuring the resulting surface morphology by AFM (Supporting Information Figure S1). The 
selective location of the amine-bearing molecules to PMMA domains was explored across large 
areas by super-resolution fluorescence images, obtained through direct stochastic optical 
reconstruction microscopy (dSTORM),32 using the Alexa Fluor 647 hydrazide fluorescent dye 
(Supporting Information Figure S2). Once optimal fabrication conditions were established (1h of 
hydrolysis at 40ºC), the surface was functionalized with ephrinB1/Fc dimers (Figures 1C and E). 
Although some PMMA domains remained without ligand coverage, the AFM measurements 
displayed nanoclusters of ephrin ligands located exclusively at the PMMA domains, indicating 
that no passivation was needed. The percentage of the total surface covered by ligands was 9.3 ± 
0.5%, as determined through AFM. dSTORM measurements confirmed, that the ephrin ligand 
was recognized by its antibody, and revealed the presence of ligand nanoclusters with a size 
distribution that was in agreement with AFM measurements (Figures 1D and F). Ligand 
nanoclusters presented a main diameter of 24.2 ± 1.1nm. Based on an estimated size of the 
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monomeric ephrinB1 proteins of 4.8 × 3 × 5.6 nm,33 we obtained a surface density value of 
~2500 ephrinB1 / Fc ligands / µm2 (~18 ephrinB1/ Fc ligands per nanocluster). Assuming that 
the density of EphA receptors on a breast cancer cell line (where the receptor is overexpressed) is 
about 800 receptors µm-2,19 the concentration of ligands in our nanopatterned surfaces was 
exceeding the concentration of receptors at the cell surface. 
 
Figure 1. Steps for fabricating a nanopatterned surface: (A) AFM topographical image 
showing hexagonal arrays of PMMA circular domains, formed by the self-assembly of diblock 
copolymer thin films. The PMMA domain main diameter is 29 ± 2 nm and particle spacing 
(center to center) is 64 ± 5 nm. The roughness of the samples is 0.8 ± 0.2 nm root mean square 
(RMS) computed over images of 2 x 2 µm. The inset shows the corresponding fast Fourier 
transform (FFT) pattern. Scale bar: 400 nm. Z-scale: 5 nm. (B) AFM topographical image of PS-
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b-PMMA thin films hydrolyzed for 1 hour at 40 ºC. The roughness of the sample is 1.0 ± 0.1 nm 
RMS (over 2 x 2 µm images). Scale bar: 400 nm. Z-scale: 5 nm. (C) AFM topographical image 
of the nanopatterns of ephrinB1/Fc dimers obtained in liquid. The functionalized area was 9.3 ± 
0.5% of the total surface area, implying that 42.3% of the total PMMA available surface had 
been successfully functionalized. The average diameter of the nanoclusters was 24.2 ± 1.1 nm 
and the mean inter-particle distance 58.4 ± 0.8 nm (center to center). Scale bar: 400 nm. Z-scale: 
15 nm. (D) dSTORM fluorescence image of the ephrinB1/Fc functionalized nanopatterns after 
conjugation with anti-Fc fluorescent antibodies. The average diameter of the nanoclusters was 27 
± 19 nm. Scale bar: 400 nm. (E) Height profile along the dashed red line in panel (C), yielding 
average nanocluster heights of ~4 nm. (F) Comparing the AFM and dSTORM size distributions 
of nanoclusters immobilized on the diblock copolymer.  
Ligand presenting surfaces. We fabricated three surfaces with diverse configurations of 
surface-bound ephrin ligands in order to test the ability of cells to sense different Eph-ephrin 
multivalent interactions (Figure 2). The first surface presented the nanopatterned configuration 
described above (Figures 2A and 2D). On the second type of surface, the ephrinB1/Fc dimeric 
ligands were presented to the cells bound to glass surfaces in a random disposition. For this 
purpose, flat elastomeric polydimethylsiloxane (PDMS) stamps were used to print ephrinB1-Fc 
molecules on top of poly-L-lysine (PLL)-coated glass. By using Poly-L-lysine to promote cell 
adhesion, the cells could be imaged using Total Internal Reflection Fluorescence (TIRF) mode. 
In direct contrast to the space-structured nanopatterned surfaces of the first approach, AFM and 
dSTORM images of this type of surface showed a random configuration of the microcontact 
printed ligands (Figures 2B and E). EphrinB1/Fc ligands displayed an intricate heterogeneous 
morphology covering ∼67% of the total area. The AFM images exhibited topographic features 
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with heights of between 4 - 6 nm, in good agreement with the sizes reported for the ephrin 
protein.33 The third surface configuration, which represents the standard approach in the field 
(see Materials and Methods section of Supporting Information), presented surface-bound 
antibody-cross-linked ephrinB1/Fc oligomers as ligands. Microcontact printing, using PDMS 
stamps, was used to immobilize antibody-crosslinked ephrinB1/Fc oligomers on PLL-coated 
glass. In the resulting AFM and dSTORM images, the oligomers appeared as extended 
conglomerates covering ∼89% of the total surface area (Figure 2C). AFM profiles showed 
features with heights between 10 - 20 nm, consistent with the size of a single layer of ephrin/Fc 
oligomers. The dSTORM images, in particular, showed that the ephrinB1/Fc ligand aggregates 
were randomly distributed across the surface (Figure 2F). For all the configurations tested, there 
is not any preferential orientation of the ligands towards the EphB2 receptors. 
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Figure 2. The three different types of ephrinB1/Fc ligand presenting surfaces characterized by 
AFM and dSTORM. Schematic representations (ephrinB1/Fc in green, anti-Fc antibodies in 
magenta, PLL in blue), topographic AFM images, and height profiles of (A) covalently bound 
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ephrinB1/Fc in a nanoclustered configuration following a nanopatterned diblock copolymer 
template; (B) ephrinB1/Fc ligand microcontact printed on a PLL-coated glass coverslip leading 
to a random disposition, and (C) antibody-conjugated ephrinB1/Fc microcontact printed on PLL-
coated glass coverslip. The height cross sections were taken along the dashed black lines. Scale 
bar: 200 nm. Z-scale: 25 nm. dSTORM analysis of surface–bound ephrinB1/Fc immunostained 
with goat anti-human IgG Alexa Fluor® 647 antibody. Panels (D) to (F) show the corresponding 
dSTORM images and 3D reconstructions of these three surface types from (A) to (C). Scale bar: 
400 nm. 
Live-cell brightness analysis. Live-cell experiments were performed with stably transfected 
human epithelial kidney 293 (HEK293T) cells, expressing the EphB2 receptor fused to the 
fluorescent protein mRuby in order to visualize receptor aggregation.18,34 The fluorescence signal 
of EphB2 receptors in live cell membranes upon interaction with ligand-functionalized substrates 
was obtained using TIRF time-lapse microscopy. TIRF images were subsequently analyzed 
using an enhanced Number and Brightness method (eN&B) to quantify EphB2 receptor 
aggregation.18 By analyzing the intensity fluctuations in each pixel, eN&B provides the 
oligomerization state (brightness) dynamics of proteins in individual living cells over the full 
time-course of their response(see Materials and Methods of Supporting Information).18,35,36 This 
information was used to build oligomerization maps for each cell, showing the color-coded 
distribution of the aggregate species (i-mers) for individual time frames (see Supporting 
Information Movies).  
The oligomerization maps of cells seeded for 60 min on surface-mediated nanopatterns of 
ephrinB1/Fc dimeric ligands (produced by diblock copolymers), showed a strong EphB2 
receptor oligomerization (brightness maps skewed towards red color). In contrast, cells seeded 
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on surfaces with a random distribution of the same ligands showed intermediate levels of 
aggregation (Figures 3A and B, and Supporting Information Movies SM1 and 2). Control 
substrates coated with PLL (Figures 3C and D) showed negligible levels of oligomerization 
during the entire 60 min observation period. The nanopatterned surface (Figure 3A) shows the 
formation of low-order oligomers that disappear over time and give rise to higher-order 
oligomeric species. These high-order oligomers were the predominant species by the end of the 
experiment. This process of appearance and depletion of individual oligomers happened in a 
remarkably synchronized way, and in good agreement with previous observations using 
microcontact printed ligand and ligand in solution.18 The random ligand disposition (Figure 3B) 
induced the assembly of low-order oligomers that did not deplete over time, at least for the 
duration of the experiment. Control samples showed no aggregation or only marginal levels of 
aggregation, probably due to spontaneous self-activation of the receptor. After 60 min of ligand 
exposure, the cells on the nanopatterned surfaces presented significantly higher average 
oligomerization values (i-merNANO = 26.3 ± 0.4) than cells stimulated without the nanopatterning 
(i-merRANDOM = 11.4 ± 0.1) (Figure 3E). Both control surfaces in the absence of the ligand (i-
merNANO-PLL = 10.6±0.2 and i-merRANDOM-PLL = 6.1±0.1) showed significantly lower levels of 
aggregation than ephrin-functionalized surfaces, indicating the specificity of the EphB2 
aggregation response against the ephrinB1/Fc ligand. The distribution of oligomeric species 60 
min after stimulation presented a broad Gaussian distribution of the nanopatterned population 
centered at 19-mers, with negligible presence of low-order oligomers (<5-mers) (Figure 3F). 
When the same ligand was presented randomly on the glass surfaces, the oligomer population 
showed a narrower distribution of species centered at 9-mers and a significant population of low-
order oligomers (<5-mers). Such low-order oligomers were the dominant species for both 
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substrates in the absence of ephrinB1/Fc ligand. Our results revealed that surface-bound 
ephrinB1/Fc ligands immobilized on surfaces are not sufficient to produce an effective EphB2 
receptor clustering, as previously stated.16 However, high-order aggregation takes place when the 
same ligands are presented in a nanopatterned configuration created through the diblock 
copolymer technology.  
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Figure 3. eN&B analysis of EphB2 clustering of HEK293T cells on glass substrates 
presenting ephrinB1/Fc dimer ligands in a nanopatterned and random fashion. TIRF images, 
oligomerization maps and i-mer plots (percentages of each aggregate, or i-mer, over time, 
normalized to the initial concentration of cell free receptors, and color-coded according to their 
increasing number of monomers) of a representative cell on (A) the nanopatterned substrate, and 
(B) random substrate, after 10 and 60 min of stimulation with the ligand (time t=0 corresponds to 
the cells’ initial contact with the surface). Every pixel in the oligomerization maps represents the 
weighted average i-mer species of the EphB2 clusters, color-coded according to the shown color 
scale. No significant oligomerization of the receptor was shown on neither of the control 
surfaces: (C) PLL on block copolymer, or (D) PLL on glass. Scale bar: 5 µm. (E) Comparing 
average oligomerization values for the four substrates (obtained from brightness values of a 
representative cell population), 10 and 60 min after ligand stimulation. Data are presented as the 
mean. Statistical differences are set to p < 0.05. (F) Distribution of average oligomerization 
values (± one standard deviation) for multiple cells at time 60 min for the nanopatterned (red) 
and the randomly distributed (blue) surface-bound ligands. The controls for the nanopatterned 
and random surfaces are shown as grey and green curves, respectively (NNANOPATTERN = 10, 
NNANO-PLL = 15, NRANDOM =19, NRANDOM-PLL = 6). 
By comparing the dynamics of the receptor clustering process between cells exposed to 
surfaces presenting the surface-bound nanopatterned ephrinB1/Fc ligands and surfaces 
presenting randomly immobilized antibody-crosslinked ephrinB1/Fc oligomers as ligands after 
60 min of ligand stimulation, we find that cells on both substrates displayed similar 
oligomerization maps and average oligomerization values (Figures 4A, B, and F). The controls 
using Poly-L-lysine coated samples showed only marginal levels of oligomerization (Figures 4C 
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and D). However, both, the snapshots of the oligomerization maps (Figure 4), and their 
corresponding time-lapse movies (Supplementary Information Movies SM3 and 4), demonstrate 
the significant effect ligand presentation has on the kinetics of the receptor clustering process. 
Upon stimulation with the nanopatterned ligand, receptor aggregation was accelerated, and low-
order species became depleted earlier (species containing between 1 and 4 receptors were 
depleted within the first 15 min), prompting the appearance of intermediate-order oligomers 
(Figures 4E and F). Indeed, by activating with nanopatterns of ephrinB1/Fc ligands, the receptor 
monomer polymerization is accelerated by 25 - 30% with shorter oligomer occurrence intervals 
(the time that elapses between the first occurrence of 10% and the depletion of 90% of the total 
population) (Figure 4G). Consequently, coalescence of intermediate-order species is also driven 
earlier than in the randomly-functionalized samples. In fact, large receptor clusters fully covered 
the cell membrane at minute 35 for the ligand nanopatterned configuration. In our previous 
studies half-maximal or full (asymptotic) tyrosine kinase activation occur when pentamers-to-
octamers, respectively, are the mean oligomers in the population.18 In the nanopatterned surfaces 
pentamers and octamers predominate at 15 - 20 min, respectively.  
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Figure 4. Nanopatterns of surface-bound ephrinB1/Fc ligands accelerate receptor 
oligomerization. Oligomerization maps at several time points after stimulation with the ligand of 
representative cells (A) on the nanopatterned substrates, and (B) the substrates presenting 
randomly distributed antibody-crosslinked ligands (time t=0 corresponds to initial contact with 
the surface). Pixels in the oligomerization maps represent the weighted average i-mer species of 
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receptor oligomers. No significant oligomerization of the receptor appeared on the control 
surfaces: (C) PLL on the block copolymer, and (D) PLL on glass. Scale bar: 5 µm. (E) 
Corresponding i-mer plots (normalized to the initial concentration) color-coded according to the 
color scale from panels (A) to (D). (F) Average oligomerization (obtained from brightness 
values) for multiple cells. Data are presented as the mean ± one standard deviation. Statistical 
differences are set to p < 0.05. (G) Time occurrence intervals (see main text) for the 
nanopatterned and antibody (AB)-clustered surfaces. (NNANOPATTERN = 10, NAB-CLUSTERS = 8). 
Interestingly, the overall surface ligand density was considerably lower for the nanopatterned 
surfaces than for the two other tested surface-ligand configurations, as evidenced by 
epifluorescence microscopy (see Supporting Information Figure S3) and dSTORM 
measurements. The AFM measurements yielded a surface coverage that was 9 times lower for 
the nanopatterned substrates compared to the antibody-conjugated ligand presenting surfaces. 
Nevertheless, our nanopatterned ligand was faster and more efficient at inducing receptor 
clustering than the other presentations. This suggests that areas with densely packed ligands may 
facilitate ligand-receptor multivalent interactions. While the antibody-crosslinking procedure 
resulted in oligomers that were mostly composed of tetramers (Supporting Information Figure 
S4), each nanocluster contained ~18 ephrinB1/Fc dimers, increasing the probability of 
multivalency. Other strategies to produce multivalent ligands have succeeded at modulating cell 
receptor signaling and cellular responses. For instance, multivalent GFP polygons controlled the 
clustering of epidermal growth factor receptors (EGFR) on cell surfaces and increased their 
internalization.3 Multivalent ligand presentation is thought to increase the probability of receptor-
ligand rebinding and hence increase multivalent effects.8,37 While earlier studies had 
hypothesized about the possibility of stimulating oligomerization and signaling of Eph receptors 
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through the immobilization of ephrin ligand oligomers on surfaces,16 our study represents the 
first experimental confirmation of this hypothesis.  
Receptor clustering is used as a signal regulatory mechanism by other tyrosine kinase receptors 
such as tropomyosin receptor kinase B (TrkB)38 and eebB2 receptor (from the human epidermal 
growth factor receptor family),39 and non-tyrosine kinase receptors such integrins,40 T cell 
receptors (TCR),41 B cell receptors (BCR)42 and bone morphogenetic protein receptors 
(BMPs).43 Ligand-receptor multivalent interactions can be also studied in these systems by the 
nanopatterning strategy presented here, as the ligand coupling chemistry can be applied to any 
amine-bearing molecule.31,44-46  
In conclusion, our results could proof that nanopatterned surfaces are much faster and more 
efficient at eliciting the formation of cell receptor clusters compared to related surface-bound 
ligand presentation strategies. While nanopatterns presented a 9-fold lower overall ligand surface 
density compared to related configurations, the presence of nanodomains with locally elevated 
ligand densities facilitated multivalent interactions that could tune the receptor aggregation 
response. Based on the intrinsic properties of block copolymers, the size and density of 
nanodomains has thus become tunable and our system has been shown to provide an ideal 
platform for the systematic study of the multivalent effects induced by surface-bound ligands on 
receptor signaling. Eph receptors and their ligands are points of corruption in cancer cell 
invasion, metastasis and angiogenesis20, and several drugs target Eph-mediated signaling as a 
strategy to control tumor invasiveness.47 In this context, our platforms provide an excellent tool 
for the development of novel pharmacological strategies that consider complex ligand-receptor 
interactions. 
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Materials and methods 
Fabrication of nanopatterned block copolymer thin films. Asymmetric, cylinder 
forming diblock copolymer PS-b-PMMA 123-35 (PS molecular weight 123000 kg/mol, 
PMMA molecular weight 35000 kg/mol, polydispersity index 1.09, polystyrene fraction 
0.78) was purchased from Polymer Source Inc. (Montreal, Canada) and used without 
further purification. The diblock copolymer was dissolved in toluene (7.5 mg/ml) at room 
temperature and stirred for 15 min. For the substrate surface modification, a random 
hydroxyl-terminated copolymer PS-r-PMMA--hydroxyl--tempo (molecular weight 
15500 kg/mol, polydispersity index 1.15, polystyrene fraction 0.71) also purchased from 
Polymer Source Inc. (Montreal, Canada) was used. The random copolymer was dissolved 
in toluene (2.5 mg/ml) at room temperature and under stirring for 15 min. Solutions of 
the random copolymer were spun-coated at 3000 rpm using a Laurell Model WS-400A-
6TFM/LITE (Laurell Technologies Corporation, North Wales, USA) spin-coater to form 
thin films on top of 18 mm diameter glass coverslips (Neuvitro, Vancouver, USA). Prior 
to the deposition, the glass coverslips were cleaned with Piranha solution (1:3, v/v, 
H2O2:H2SO4) and activated 2 min in O2 plasma in an Expanded Plasma Cleaner PDC-002 
plasma cleaner (Harrick Scientific Corporation, New York, USA). Caution: piranha acid 
is a strong oxidizer and a strong acid. It should be handled with extreme care, as it 
reacts violently with most organic materials. The random copolymer thin films were then 
thermally annealed under vacuum (VacioTem-T Selecta Oven, Barcelona, Spain) at 
220ºC, which is above the glass transition temperatures Tg for the PS (Tg = 100ºC) and 
PMMA (Tg = 115ºC), for 7 days. This process allows the hydroxyl end-functional groups 
of the random copolymer diffuse to the glass surface and react with the silanol groups on 
the silicon oxide-based substrate through a condensation reaction.1 This process results 
in polymer chain brushes anchored to the substrate forming a brush layer. After 
S3 
 
immersion and rinsing with toluene to remove the unreacted polymer chains, we 
characterized the thickness and the surface morphology of the brush layer formed by 
atomic force microscopy (AFM) technique, using a Dimension AFM instrument (Veeco 
Instruments, New York, USA). Measurements were performed in tapping mode and using 
a rectangular silicon AFM tip (Nanosensors, PPP-NCHR, spring constant 42 N/m, 
resonance frequency 330 KHz radius of curvature about 10 nm, aluminium backside 
coating, and 125 μm in length). The thickness of the layer was determined through the 
measure of purpose made scratches and was 5 nm. Subsequently, thin films of the PS-
b-PMMA block copolymer were deposited again by spin coating (3000 rpm) onto the 
samples modified with the random copolymer. The block copolymer thin films were then 
thermally annealed under vacuum at 220ºC for 3 hours. It has been reported that an 
effectively neutral free surface can be created in the PS-b-PMMA system by annealing 
films between ≈170 °C to 230 °C, where the block surface tensions are approximately 
equal.2,3 The thickness ( 42 nm) and morphology of the block copolymer were examined 
by AFM (Supporting information, figure 1b), where the PMMA domains appear to be 
brighter than the PS matrix due to viscoelastic contract between the two block 
components.4 Once fabricated, the samples were stored at room temperature until further 
use. 
Functionalization of the nanopatterned templates. The selective formation of 
carboxylic groups on the surface of the PMMA domains of the block copolymer samples 
was generated by the immersion of the PS-b-PMMA glass coverslips into a sodium 
hydroxide (Panreac Química S. A. U., Barcelona, Spain) 2 M solution at 40ºC. Previous 
works have reported that the functionalization of the PMMA through this method depends 
on the immersion time285, so times ranging from 10 min to 5 h were assayed to determine 
the optimal conditions. Hydrolysed samples were characterized in their morphology by 
S4 
 
AFM. Attempts to determine the presence of the carboxylic groups on the surface through 
X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared spectroscopy 
(FTIR) were not successful, probably due to resolution limitations. Therefore, the optimal 
conditions for the hydrolysis procedure were determined from the characterization of the 
samples after the immobilization with amine-bearing biomolecules. For this purpose, 
after the hydrolysis, the samples were neutralized with 0.1 M hydrochloric acid solution 
(37%, Panreac Química S. A. U., Barcelona, Spain) and carboxylic acid groups were 
reacted with the amino groups of several biomolecules. This reaction requires the prior 
activation of the carboxylic acid moieties. This was performed by placing the coverslip 
in contact with a mixture of N-(3-dimethylaminopropyl)-N -ethyl carbodiimide (EDC) 
(73.4 mg, 0.38 mmol) and N-hydroxysuccinimide (NHS) (8.9 mg, 0.08 mmol) in Milli-Q 
water (5 mL) at room temperature for 30 min. Both EDC and NHS reagents were 
purchased from Sigma-Aldrich Química S. L. (Madrid, Spain). Then the samples were 
washed thoroughly with Milli-Q water and dried with nitrogen gas. On these samples, we 
immobilized both amine-fluorescent dyes and ephrinB1/Fc proteins. Substrates were 
incubated with 100 µL of a solution of Alexa Fluor 647 hydrazide fluorescent dye 
(Thermo Fisher Scientific, Waltham, USA) 0.5 mg/mL in Milli-Q overnight at room 
temperature. Alternatively, samples were incubated with 200 µL of 0.2 µM mouse 
ephrinB1/Fc Chimera (R&D Systems Inc., Minneapolis, USA) solution in 0.05% v/v 
Tween 20 Phosphate Buffer Saline (PBS) overnight. After rinsing with 0.05% v/v Tween 
20 PBS, samples were stored at 4ºC until further use.  
Functionalized nanopatterned samples were characterized by AFM. Measurements were 
performed in liquid (PBS), working in tapping mode and using a triangular silicon nitride 
AFM probe (Bruker AFM Probes, DNP-S10, spring constant 0.12 N/m, resonance 
frequency 23 KHz, radius of curvature about 10 nm, reflective gold as back side coating 
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and 205 µm and 40 µm in length and width respectively). In addition, samples with the 
nanopatterns of the fluorescent dyes and the ephrinB1/Fc proteins were then imaged with 
a commercial super-resolution direct stochastic optical reconstruction microscope 
(dSTORM) system from Nikon instruments (Nikon Instruments Europe B.V., 
Amsterdam, The Netherlands). Samples were excited with laser light at 647 nm through 
an oil immersion 100x TIRF 1.49NA objective. The emission fluorescence was obtained 
using an electron multiplying charge coupled device (EMCCD) camera at an exposure 
time of 100 ms per frame. Imaging of samples functionalized with the Alexa Fluor 647 
dye was performed in a 5% glucose solution in PBS in the presence of primary thiol (25 
µL of 0.1 µg/mL mercaptoethylamine in 1 M hydrochloric acid solution purchased from 
Sigma-Aldrich Química, Spain) and an enzymatic oxygen–scavenging system (2.5 µL of 
glucose oxydase (Sigma-Aldrich Química, Spain)), which enhances photostability and 
photoswitching properties of the dye.6 EphrinB1/Fc proteins were labelled with an 
antibody bearing an Alexa Fluor 647 dye. For data analysis we used Visual Servoing 
Platform (VISP) software7 and the ThunderSTORM plugin of ImageJ free software 
(http://rsb.info.nih.gov/ij, National Institutes of Health, USA). EphrinB1/Fc 
functionalized substrates were incubated with a 200 µl of a solution containing a 
secondary antibody to Fc (goat anti-human Fc Alexa Fluor 647, Thermo Fisher Scientific, 
Waltham, USA) in PBS (1:200) for 45 min, rinsed with PBS and dried under nitrogen 
flow. For the imaging, samples were mounted on in-house made bottom-glass petri dishes 
and measures were performed under the same conditions previously described.  
For live cell experiments, cell adhesion on ephrinB1/Fc nanopatterned samples was 
promoted by incubating the samples with 300 µl of poly-L-lysine (PLL) (Sigma-Aldrich 
Química S.L., Madrid, Spain) solution at 0.05% (w/v) in PBS during 90 min. After rinsing 
with PBS and Milli-Q water, samples were glued on 35 mm in-house made glass-bottom 
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petri dishes. Control samples were produced by coating the hydrolysed block copolymer 
samples only with PLL.  
Preparation of ephrinB1/Fc samples immobilized on glass coverslips. Glass bottom 
dishes 35 mm in diameter (MatTek Corporation, Ashland, USA) were coated with 300 µl 
of poly-L-lysine (PLL) solution at 0.05% (w/v) in PBS to promote cell adhesion. Samples 
were incubated with the PLL solution for 90 min and then rinsed with PBS and Milli-Q 
water. On top of these PLL-coated glass surfaces, ephrinB1/Fc was immobilized either 
as dimers (that is, as supplied) or as oligomers. EphrinB1/Fc oligomers were generated 
by conjugating eprhinB1/Fc dimers with anti-Fc antibody in solution. Goat Anti-Human 
IgG (Jackson ImmunoResearch Laboratories Inc., West Grove, USA) at a 2:5 molar ratio 
for 30 min under constant shaking. The immobilization of dimers or oligomers of 
ephrinB1/Fc was performed by printing using flat polydimethylsiloxane (PDMS) stamps 
(SYLGARD® 184, Ellsworth Adhesives, Dow Corning, Germany). PDMS stamps were 
fabricated by mixing a 10:1 mass ratio of silicon elastomer base and curing agent. PDMS 
was degassed under vacuum, poured on flat Petri dishes and cured overnight at 60ºC. 
Stamps were cut in 12 mm round discs and cleaned with ethanol in an ultrasonic bath for 
5 min. Thereafter, stamps were inked with either 100 µl of ephrinB1/Fc dimer solution 2 
µM in PBS or 145 µl of 2 µM ephrinB1/Fc oligomer solution in PBS for 45 min. 
Afterwards, the stamps were thoroughly rinsed with PBS and Milli-Q water and air dried. 
Inked stamps were brought into conformal contact with previously PLL-coated glass 
surfaces for 10 min. Flat stamps were carefully removed and ephrinB1/Fc dimers or 
oligomers were transferred to the surface. After printing, surfaces were rinsed with PBS 
and Milli-Q water. PLL-coated glass surfaces as well as PLL-coated surfaces 
functionalized with Recombinant Human IgG1 Fc (R&D Systems Inc., Minneapolis, 
USA) were used as controls.  
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The hydrodynamic diameters of oligomers generated by antibody-conjugated 
ephrinB1/Fc were determined by dynamic light scattering (DLS). The particle size 
distribution was measured by intensity at 25 ºC using a Möbius instrument (Wyatt 
Technology Corp., Santa Barbara, CA, USA) equipped with a 532-nm laser and a 
scattering angle of 163.5˚. The samples were prepared conjugating ephrinB1/Fc dimers 
with goat anti-human IgG at 2:5 molar ratio for 30 min under constant shaking. As 
control, goat anti-human IgG antibody solution was also measured. Measurements were 
performed immediately after clustering using the Möbius dip cell. Three independent 
samples were measured in triplicate. Dynamics software (Wyatt Technology Corp., Santa 
Barbara, CA, USA) was used for data acquisition and data treatment. The size and 
distribution of the oligomers on the PLL-coated glass surfaces after the printing procedure 
was characterized by AFM in liquid and by dSTORM, following the same procedure used 
for the characterization of the ephrinB1/Fc dimers disposal on the nanopatterned 
templates.  
Cell culture. HEK293T:EphB2_mRuby transgenic cells express the ephB2 receptor 
fused to the bright, monomeric fluorescent protein mRuby, which minimizes the 
probability of spontaneous receptor aggregation.8 The fluorescent protein is inserted in 
the juxtamebrane region of EphB2, which also minimizes the interference with the 
receptor signal.9 The origin of the cells has been described before.10 The stock of cells 
was maintained using complete DMEM at 10% fetal bovine serum supplementation. The 
cells were always kept at low passage for the imaging experiments. Cell splitting was 
carried out using 0.025% trypsin-EDTA (Gibco, Thermo Fisher Scientific, USA) every 
2-3 days. 
Live cell imaging experiments. For every experiment, approximately 106 cells where 
freshly harvested from a culture plate and gently resuspended in DMEM without phenol 
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red for immediate use. The cell suspension was then transferred into the ligand-
functionalized substrates plates containing the dimers, the oligomers or the nanopatterned 
ligands, and spun down using a plate centrifuge at 1000 rpm for 1 minute. For all the 
experiments, the clock was set to zero at the end of the centrifugation process. The 
samples were then quickly taken to the microscope for observation. 
We acquired the time-lapse image series using the TIRF mode of a commercial STORM 
microscope system (Nikon Instruments Europe B.V., Amsterdam, The Netherlands) 
equipped with an EMCCD camera (Andor iXon3 897), 1.4 NA 100x objective and a 1.5x 
lens tube for additional magnification. TIRF allows the illumination of only the cell 
membrane in direct contact with the ligand-presenting surfaces. Cells were illuminated 
with 561 nm light at low laser intensity (3 W/cm2 power density) for 200 frames with 500 
ms exposure time. Waiting time between time points was 2.5 minutes. We acquired 
multiple time point datasets of the same specimen over approximately 60 minutes and 
apply enhanced number and brightness (eN&B) analysis technique to map the EphB2 
receptor aggregation over time. 
Enhanced Number and Brightness analysis. TIRF images were analysed following the 
enhanced Number and Brightness (eN&B) analysis procedure described elsewhere. N&B 
is an image analysis tool that distinguishes pixels with different aggregation states 
(Brightness) by determining the mean intensity and variance of their relative fluorescence 
intensity fluctuations.11 eN&B uses a statistical resampling method to procure the relative 
distribution of oligomers contained at every pixel (ref paper original). eN&B also allows 
to time-resolve long oligomerization processes (in the range of tens of minutes) and 
describes the evolution of such oligomerization state over the time. The brightness of the 
mRuby monomer has been calculated before. Cells undergoing apoptosis and out of the 
TIRF evanescent wave focal plane were excluded from the analysis. 
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Supporting Information Additional Figures 
 
Supporting information Figure S1. Optimization of the PMMA hydrolysis procedure. 
AFM images of sample topography (in air) after ample hydrolysis and functionalization 
with Alexa Fluor 647 hydrazide fluorescent dye. (A) 30 min of hydrolysis time at 40ºC 
without agitation; (B) 30 min of hydrolysis time at 40ºC with agitation; (C) 1 h of 
hydrolysis at 40ºC with agitation and (D) 5 h of hydrolysis at 40ºC with agitation. Scale 
bar 400 nm; Z-scale: 10 nm. Images were processed and analysed using WSxM software. 
First, images were flattened (simple flatten) and then the flooding algorithm was used to 
determine the size and distribution of the functionalized areas (attributed to regions with 
A B
C D
E
0 25 50 75 100
0
10
20
0 25 50 75 100
0
10
20
0 25 50 75 100
0
10
20
R
e
la
ti
v
e
 F
re
q
u
e
n
c
y
0 25 50 75 100
0
10
20
Cluster size (nm)
xc = 33,9 nm
xc = 32,1 nm
xc = 28,1 nm
xc = 35,9 nm
B 
C 
D’
A A B
C D
E
Hydrolysis condition Functionalized domain/µm2
Interparticle distance 
(nm)
A 85 ± 21 72 ± 6
B 86 ± 17 65 ± 2
C 105 ± 19 58 ± 0
D 60 ± 16 72 ± 3
F
S10 
 
heights from 4 to 12 nm). (E) Histograms of fluorescence ligand cluster size for the 
evaluated functionalization conditions (A to D) and the most frequent diameter found on 
each surface. (F) Table summarizing the parameters analysed for hydrolysis conditions 
(A) to (D). Hydrolysis condition (C), leading to the highest density of individual 
functionalized domains was selected. 
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Supporting information Figure S2. Alexa Fluor 647 hydrazide fluorescent dye 
nanopatterns are visible by AFM (A to C panels) and dSTORM measurements (D to F 
panels) at several magnifications. The average size of the clusters was determined as 
27±11 nm from the AFM images and as 27±19 nm from the dSTORM pictures, in good 
agreement with the size of the PMMA domains on the block copolymer thin films. Scale 
bar: 3 µm for A and D; 1 µm for B and E; 400 nm for C and F; Z-scale for AFM images: 
10 nm). 
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Supporting information Figure S3. (A) Fluorescence microscopy pictures of surface–
bound ephrinB1/Fc ligands for the different configurations assayed. Samples were 
immunostained with goat anti-human IgG Alexa Fluor® 647 antibody. Scale bar: 400 
nm. (B) Average fluorescence intensity of immunostained samples. Statistically 
significant differences were found between the three functionalized surfaces (p < 0.05). 
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Supporting information Figure S4. Dynamic Light Scattering (DLS) measurements. 
Size distribution of (A) goat anti-human IgG antibody and (B) antibody-conjugated 
ephrinB1/Fc. The IgG antibody has an average size of 9±1 nm in diameter, correlating 
with the size reported for the goat anti-human IgG protein. Ephrin B1/Fc oligomers 
exhibit a main peak of 72±4 nm in diameter, in agreement with the AFM measurements. 
This peak corresponds to tetramers (dimers of ephrinB1/Fc dimers), in agreement with 
measurements reported for the same crosslinking procedure.14 Average values from n = 
3 independent samples are show. 
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Supporting Information Movies 
 
Supporting information Movie SM1 (SM1.AVI FILE). Time-lapse movie of the 
oligomerization map of a cell interacting with ephrinB1/Fc dimers on a random 
disposition on the substrate.  
 
Supporting information Movie SM2 (SM2.AVI FILE). Time-lapse movie of the 
oligomerization map of a cell interacting with ephrinB1/Fc dimers on nanopatterned 
disposition on the substrate.  
 
Supporting information Movie SM3 (SM3.AVI FILE). Time-lapse movie of the 
oligomerization map of a cell interacting with ephrinB1/Fc dimers on nanopatterned 
disposition on the substrate.  
 
Supporting information Movie SM4 (SM4.MP4 FILE). Time-lapse movie of the 
oligomerization map of a cell interacting with antibody-conjugated ephrinB1/Fc dimers 
on a random disposition on the substrate.  
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